Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects

Detalhes bibliográficos
Autor(a) principal: Tej, Rabeb
Data de Publicação: 2019
Outros Autores: Hamdi, Amel, Beji, Raja Serairi, Wanne, Wissem Aidi, Rebey, Iness Bettaieb, Oueslati, Samia, Ksouri, Riadh, Tounsi, Moufida Saidani, Lachaal, Mokhtar, Bouraoui, Najoua Karray
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/164855
Resumo: The purpose of the present investigation is to assess, for the first time, the antidiabetic, antihyperlipidemic and antioxidant activities of Lycium europaeum extract in alloxan-induced diabetic rats. Diabetes was induced in adult male Wistar rats via a single subcutaneous alloxan injection (120 mg/kg). Lycium europaeum aqueous extract was orally administered at a dose of 20 mg/kg for 28 consecutive days. Serum concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were assayed at the end of the experimental period in all investigated groups. Antioxidant enzymes such as glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) were sought in the serum and pancreas. Lycium europaeum extract significantly increased HDL-C and reduced blood glucose, TC, LDL-C and TG as compared to the alloxan-control group. Lycium europaeum extract was also efficient in reducing oxidative stress in diabetic rats by increasing SOD, CAT and GPx activities both in the pancreas and the plasma of the animals. Moreover, Lycium europaeum extract contained considerable levels of polyphenols and flavonoids. It also exhibited an important antioxidant capacity and a remarkable ability to quench DPPH radicals and reduce irons. The obtained results highlight potentially relevant health beneficial effects of Lycium europaeum extract, reversing hyperglycemic, hyperlipidemic and oxidative stress effects in rats with alloxan-induced diabetes. Therefore, it may be considered as a promising alternative or complementary agent to diabetes treatment.
id USP-31_6a54dbf6319906390e3a5baff2e7b0a0
oai_identifier_str oai:revistas.usp.br:article/164855
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effectsLycium europaeum/extract/antihyperglycemiaLycium europaeum/extract/antioxidant activityLycium europaeum/extract/antihyperlipidemiaThe purpose of the present investigation is to assess, for the first time, the antidiabetic, antihyperlipidemic and antioxidant activities of Lycium europaeum extract in alloxan-induced diabetic rats. Diabetes was induced in adult male Wistar rats via a single subcutaneous alloxan injection (120 mg/kg). Lycium europaeum aqueous extract was orally administered at a dose of 20 mg/kg for 28 consecutive days. Serum concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were assayed at the end of the experimental period in all investigated groups. Antioxidant enzymes such as glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) were sought in the serum and pancreas. Lycium europaeum extract significantly increased HDL-C and reduced blood glucose, TC, LDL-C and TG as compared to the alloxan-control group. Lycium europaeum extract was also efficient in reducing oxidative stress in diabetic rats by increasing SOD, CAT and GPx activities both in the pancreas and the plasma of the animals. Moreover, Lycium europaeum extract contained considerable levels of polyphenols and flavonoids. It also exhibited an important antioxidant capacity and a remarkable ability to quench DPPH radicals and reduce irons. The obtained results highlight potentially relevant health beneficial effects of Lycium europaeum extract, reversing hyperglycemic, hyperlipidemic and oxidative stress effects in rats with alloxan-induced diabetes. Therefore, it may be considered as a promising alternative or complementary agent to diabetes treatment.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16485510.1590/s2175-97902019000118064Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18064Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18064Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e180642175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164855/158014Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessTej, RabebHamdi, AmelBeji, Raja SerairiWanne, Wissem AidiRebey, Iness BettaiebOueslati, SamiaKsouri, RiadhTounsi, Moufida SaidaniLachaal, MokhtarBouraoui, Najoua Karray2019-12-06T18:54:18Zoai:revistas.usp.br:article/164855Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-12-06T18:54:18Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
title Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
spellingShingle Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
Tej, Rabeb
Lycium europaeum/extract/antihyperglycemia
Lycium europaeum/extract/antioxidant activity
Lycium europaeum/extract/antihyperlipidemia
title_short Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
title_full Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
title_fullStr Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
title_full_unstemmed Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
title_sort Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
author Tej, Rabeb
author_facet Tej, Rabeb
Hamdi, Amel
Beji, Raja Serairi
Wanne, Wissem Aidi
Rebey, Iness Bettaieb
Oueslati, Samia
Ksouri, Riadh
Tounsi, Moufida Saidani
Lachaal, Mokhtar
Bouraoui, Najoua Karray
author_role author
author2 Hamdi, Amel
Beji, Raja Serairi
Wanne, Wissem Aidi
Rebey, Iness Bettaieb
Oueslati, Samia
Ksouri, Riadh
Tounsi, Moufida Saidani
Lachaal, Mokhtar
Bouraoui, Najoua Karray
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Tej, Rabeb
Hamdi, Amel
Beji, Raja Serairi
Wanne, Wissem Aidi
Rebey, Iness Bettaieb
Oueslati, Samia
Ksouri, Riadh
Tounsi, Moufida Saidani
Lachaal, Mokhtar
Bouraoui, Najoua Karray
dc.subject.por.fl_str_mv Lycium europaeum/extract/antihyperglycemia
Lycium europaeum/extract/antioxidant activity
Lycium europaeum/extract/antihyperlipidemia
topic Lycium europaeum/extract/antihyperglycemia
Lycium europaeum/extract/antioxidant activity
Lycium europaeum/extract/antihyperlipidemia
description The purpose of the present investigation is to assess, for the first time, the antidiabetic, antihyperlipidemic and antioxidant activities of Lycium europaeum extract in alloxan-induced diabetic rats. Diabetes was induced in adult male Wistar rats via a single subcutaneous alloxan injection (120 mg/kg). Lycium europaeum aqueous extract was orally administered at a dose of 20 mg/kg for 28 consecutive days. Serum concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were assayed at the end of the experimental period in all investigated groups. Antioxidant enzymes such as glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) were sought in the serum and pancreas. Lycium europaeum extract significantly increased HDL-C and reduced blood glucose, TC, LDL-C and TG as compared to the alloxan-control group. Lycium europaeum extract was also efficient in reducing oxidative stress in diabetic rats by increasing SOD, CAT and GPx activities both in the pancreas and the plasma of the animals. Moreover, Lycium europaeum extract contained considerable levels of polyphenols and flavonoids. It also exhibited an important antioxidant capacity and a remarkable ability to quench DPPH radicals and reduce irons. The obtained results highlight potentially relevant health beneficial effects of Lycium europaeum extract, reversing hyperglycemic, hyperlipidemic and oxidative stress effects in rats with alloxan-induced diabetes. Therefore, it may be considered as a promising alternative or complementary agent to diabetes treatment.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164855
10.1590/s2175-97902019000118064
url https://www.revistas.usp.br/bjps/article/view/164855
identifier_str_mv 10.1590/s2175-97902019000118064
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164855/158014
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18064
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18064
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18064
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1787713371911487488